
Lupin Limited has informed the Exchange regarding a press release dated February 06, 2024, titled "Lupin Receives Approval from U.S. FDA for Bromfenac Ophthalmic Solution, 0.075%.".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated February 06, 2024, titled "Lupin Receives Approval from U.S. FDA for Bromfenac Ophthalmic Solution, 0.075%.".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin